You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Baxter
Boehringer Ingelheim
Moodys
Dow

Last Updated: February 25, 2020

DrugPatentWatch Database Preview

Solvay Company Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for SOLVAY, and what generic and branded alternatives to SOLVAY drugs are available?

SOLVAY has sixty-three approved drugs.



Summary for Solvay
US Patents:0
Tradenames:45
Ingredients:34
NDAs:63
Patent Litigation for Solvay: See patent lawsuits for Solvay

Drugs and US Patents for Solvay

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay TRANMEP meprobamate TABLET;ORAL 016249-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Solvay SYMADINE amantadine hydrochloride CAPSULE;ORAL 071000-001 Sep 4, 1986 DISCN No No   Start Trial   Start Trial
Solvay RETET tetracycline hydrochloride CAPSULE;ORAL 061443-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Solvay R-P MYCIN erythromycin TABLET, DELAYED RELEASE;ORAL 061659-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Solvay

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-001 Dec 5, 1994 4,085,225   Start Trial
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-004 Dec 5, 1994 4,085,225   Start Trial
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-002 Dec 5, 1994 4,085,225   Start Trial
Solvay LUVOX fluvoxamine maleate TABLET;ORAL 020243-003 Dec 5, 1994 4,085,225   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
Colorcon
McKesson
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.